LDLR and Obesity: In LDL-receptor knockout Leiden mouse models (LDLr−/−) with non-alcoholic fatty liver disease (NAFLD) and obesity, HP-EVOO intake significantly reduced adipose tissue hypertrophy [36,37,38,39,41,42].